JP Patent

JP2008533105A — アシル化ｇｌｐ−１化合物

Assigned to Novo Nordisk AS · Expires 2008-08-21 · 18y expired

What this patent protects

長く伸びたGLP-1化合物およびその治療上の使用。

USPTO Abstract

長く伸びたGLP-1化合物およびその治療上の使用。

Drugs covered by this patent

Patent Metadata

Patent number
JP2008533105A
Jurisdiction
JP
Classification
—
Expires
2008-08-21
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.